Amelioration of delayed-type hypersensitivity responses by IL-27 administration
Authors:
- Hiroki YoshidaHYHiroki Yoshida
- 1 August 2008
- journal article
- research article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 373 (3) , 397-402
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- A dominant function for interleukin 27 in generating interleukin 10–producing anti-inflammatory T cellsNature Immunology, 2007
- Suppression of autoimmune inflammation of the central nervous system by interleukin 10 secreted by interleukin 27–stimulated T cellsNature Immunology, 2007
- Interleukins 27 and 6 induce STAT3-mediated T cell production of interleukin 10Nature Immunology, 2007
- Expanding the effector CD4 T-cell repertoire: the Th17 lineageCurrent Opinion in Immunology, 2006
- The IL-27 Receptor Chain WSX-1 Differentially Regulates Antibacterial Immunity and Survival during Experimental TuberculosisThe Journal of Immunology, 2005
- The IL-27R (WSX-1) Is Required to Suppress T Cell Hyperactivity during InfectionImmunity, 2003
- WSX-1 Is Required for Resistance to Trypanosoma cruzi Infection by Regulation of Proinflammatory Cytokine ProductionImmunity, 2003
- Cutting Edge: Role of IL-27/WSX-1 Signaling for Induction of T-Bet Through Activation of STAT1 During Initial Th1 CommitmentThe Journal of Immunology, 2003
- IL-27, a Heterodimeric Cytokine Composed of EBI3 and p28 Protein, Induces Proliferation of Naive CD4+ T CellsImmunity, 2002
- WSX-1 Is Required for the Initiation of Th1 Responses and Resistance to L. major InfectionImmunity, 2001